How much does stem cell therapy for Premature Ovarian Insufficiency cost? (2026)
The comparison dataset stores a Bulgaria planning observation of €3,000–€8,000 for treatment, compiled from cited public commercial sources. It is not a quotation from Stem Plus, and different products, doses, visits and inclusions must not be treated as equivalent. The stored registry query contains 35 Premature Ovarian Insufficiency records. Registration does not mean that a study is recruiting, that a person is eligible, or that treatment and travel are free; verify the current record and sponsor-cost terms directly.
Premature ovarian insufficiency (POI) is loss of ovarian function before age 40, confirmed through menstrual history and biochemical assessment. It can affect fertility, bone, cardiovascular, sexual and psychological health. Causes and residual ovarian activity vary. Mesenchymal stromal cells (MSCs) and other biological approaches are being studied, but proposed follicle, hormonal or immune mechanisms have not established restored fertility or live birth. Cell injection or infusion is not standard POI care. The registry table on this page lists relevant studies and their current recruitment status.
What drives the cost for Premature Ovarian Insufficiency
Private investigational POI cell procedures can involve separate charges for ovarian injection, anaesthesia, hormone testing, imaging, fertility treatment, cryopreservation, monitoring and travel. Prices do not indicate regulatory approval, ovarian restoration or pregnancy benefit. Patients should request an itemised written quote separating research procedures from IVF and standard care, and verify sponsor, insurer and patient responsibilities.
POI cell-therapy evidence is early and heterogeneous. Menstruation, hormone levels, ultrasound follicles, oocyte retrieval, pregnancy and live birth are different outcomes and must not be treated as interchangeable. Small uncontrolled series cannot establish that an intervention restored ovarian function or caused a pregnancy. No pooled response rate is published here because product, route, patient selection and endpoints differ too widely. The registered studies and their own prespecified endpoints are listed in the registry table on this page.
Premature Ovarian Insufficiency cost by country — comparison (2026)
| Location | Indicative treatment cost | Regulation |
|---|---|---|
| Bulgaria (EU) · e.g. Stem Plus | €3,000–€8,000 | Verify provider and laboratory certificates |
| USA | €4,600–€46,000 | Non-EU; verify provider and product status |
| UK | €4,880–€49,000 | Non-EU; verify provider and product status |
| Germany | €11,000–€36,700 | EU member state; verify provider and product status |
| Switzerland | €20,000–€40,000 | Non-EU; verify provider and product status |
| Mexico | €3,000–€12,000 | Non-EU; verify provider and product status |
| India | €3,000–€8,000 | Non-EU; verify provider and product status |
| Serbia | €7,000–€31,000 | Non-EU; verify provider and product status |
| Turkey | €6,000–€18,000 | Non-EU; verify provider and product status |
| Thailand | €8,000–€20,000 | Non-EU; verify provider and product status |
| Panama | €15,000–€27,000 | Non-EU; verify provider and product status |
Price varies with cell type, dose, number of sessions, diagnostics, supportive care and follow-up. A lower range does not establish equivalent quality or outcome. Request a fixed written quote and verify the therapy and provider with the relevant authorities. Check registered trials before paying privately.
Premature Ovarian Insufficiency cost — common questions
Why is Premature Ovarian Insufficiency stem-cell treatment so much cheaper in Bulgaria?
The collected commercial ranges differ, but they may describe different products, doses, visits and inclusions. A lower quote does not establish equivalent quality, evidence or regulatory status.
Is a cheaper programme riskier?
Price alone cannot establish risk. Verify the exact treatment status, provider and manufacturing authorisations, product identity, release testing, adverse-event plan and primary evidence.
Does the price include travel and hotel?
The €3,000–€8,000 range covers the medical programme. Add flights, hotel and recovery with our calculator for your true all-in cost from your city.
Will I get a fixed quote, or an open-ended bill?
Ask for a written quotation after clinical review, with the exact product, inclusions, exclusions, cancellation terms and circumstances in which charges may change. A website estimate is not a binding quote.
Sources & further reading
We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.
- Open clinical trials for Premature Ovarian Insufficiency (ClinicalTrials.gov) ↗
- Peer-reviewed research on PubMed ↗
- ISSCR patient guide — what to ask ↗
- FDA consumer warning on stem-cell therapies ↗
- EMA — advanced-therapy (ATMP) framework ↗
Indicative ranges for planning, compiled from public market data; confirmed pricing follows a medical review. Not medical advice.
More on this condition
- Premature Ovarian Insufficiency: cell-therapy evidence and registered trials
- Premature Ovarian Insufficiency stem cell therapy — your questions answered (2026)
- Premature Ovarian Insufficiency: cell-therapy evidence by therapy class
- MSC vs PRP for Premature Ovarian Insufficiency: what the registries show